The US has exempted Indian pharmaceuticals from tariffs amidst President Trump’s broad tariff imposition, recognizing their crucial role in global healthcare. This move reinforces India’s position as a key provider of affordable generic medicines. Leaders highlight the strategic importance of the bilateral trade relationship, with the exemption offering India a chance to enhance its pharmaceutical sector.
Related Posts
‘His remark on Northeast misinterpreted’: Aide of Yunus
A senior aide of Bangladesh’s interim government head Muhammad Yunus clarified that Muhammad Yunus’ remark about India’s seven northeastern states was made with honest intentions […]
World’s priciest Dinosaur fossil arrives in New York with a staggering price tag
Billionaire Kenneth Griffin’s record-breaking stegosaurus fossil, nicknamed Apex, will be displayed at the American Museum of Natural History for four years. The loan allows public […]